Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 6.28% vs 10.51% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 260.00% vs -2.17% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "174.30",
          "val2": "164.00",
          "chgp": "6.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.90",
          "val2": "8.20",
          "chgp": "-3.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.10",
          "val2": "2.70",
          "chgp": "14.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.00",
          "val2": "1.80",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.20",
          "val2": "4.50",
          "chgp": "260.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "45.10%",
          "val2": "-12.00%",
          "chgp": "5.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -4.29% vs -21.78% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -43.00% vs -47.24% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "632.00",
          "val2": "660.30",
          "chgp": "-4.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "64.90",
          "val2": "82.60",
          "chgp": "-21.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "12.70",
          "val2": "14.00",
          "chgp": "-9.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.10",
          "val2": "6.40",
          "chgp": "-164.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "28.90",
          "val2": "50.70",
          "chgp": "-43.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.10%",
          "val2": "52.90%",
          "chgp": "-1.88%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

174.30

164.00

6.28%

Operating Profit (PBDIT) excl Other Income

7.90

8.20

-3.66%

Interest

3.10

2.70

14.81%

Exceptional Items

3.00

1.80

66.67%

Consolidate Net Profit

16.20

4.50

260.00%

Operating Profit Margin (Excl OI)

45.10%

-12.00%

5.71%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 6.28% vs 10.51% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 260.00% vs -2.17% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

632.00

660.30

-4.29%

Operating Profit (PBDIT) excl Other Income

64.90

82.60

-21.43%

Interest

12.70

14.00

-9.29%

Exceptional Items

-4.10

6.40

-164.06%

Consolidate Net Profit

28.90

50.70

-43.00%

Operating Profit Margin (Excl OI)

34.10%

52.90%

-1.88%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -4.29% vs -21.78% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -43.00% vs -47.24% in Dec 2024

All Annual Results